Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease

Neuroscience Letters

Volumn 555, Issue , 2013, Pages 102-105

  Björkhem, Ingemar ^a   Lövgren Sandblom, Anita ^a   Leoni, Valerio ^b   Meaney, Steve ^c   Brodin, Lovisa ^a   Salveson, Lisette ^d   Winge, Kristian ^d   Pålhagen, Sven ^a   Svenningsson, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^d BISPEBJERG HOSPITAL   (Denmark)

Author keywords

24S hydroxycholesterol; 27 Hydroxycholesterol; Biomarkers; Oxysterols

Indexed keywords

24S HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; OXYSTEROL; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

24S-HYDROXYCHOLESTEROL; 27-HYDROXYCHOLESTEROL; BIOMARKERS; OXYSTEROLS;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYDROXYCHOLESTEROLS; MALE; MIDDLE AGED; PARKINSON DISEASE; TIME FACTORS;

EID: 84885120728     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.09.003     Document Type: Article

References (12)

1. Björkhem I., Meaney S. Brain cholesterol - long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 2004, 24:806-815.
2. Lütjohann D., Breuer O., Ahlborg G., Nennesmo I., Sidén et al Å. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:9799-9804.
3. Heverin M., Meaney S., Lütjohann D., Diczfalusy U., Wahren J., Björkhem I. Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain and possible consequences for cerebral cholesterol homeostasis. J. Lipid Res. 2005, 46:1047-1052.
4. Bretillon L., Sidén Å., Wahlund L., Lutjohann D., Minthon L., Crisby M., Hillert J., Groth C., Diczfalusy U., Björkhem I. Plasma levels of 24S-hydroxycholesterol in neurological patients. Neurosci. Lett. 2000, 293:87-90.
5. Leoni V., Masterman T., Mousavi F., Wretlind B., Wahlund L.O., Diczfalusy U., Hillert J., Björkhem I. Diagnostic use of cerebral and extracerebral oxysterols. Clin. Chem. Lab. Med. 2004, 42:186-191.
6. Leoni V., Shaafati M., Solomon A., Kivipelto M., Björkhem I., Wahlund L.-O. Are the CSF levels of 24S-hydroxycholesterol a suitable biomarker for mild cognitive impairment?. Neurosci. Lett. 2006, 397:83-87.
7. Solomon A., Leoni V., Kivipelto M., Besga A., Öksengård A.R., Julin P., Svensson L., Wahlund L.O., Andreasen N., Winblad B., Soininen H., Björkhem I. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. Neurosci. Lett. 2009, 462:89-93.
8. Leoni V., Caccia C. Oxysterols as biomarkers in neurodegenerative diseases. Chem. Phys. Lipids 2011, 164:512-524.
9. Lee C.Y., Seet R.C., Huang S.H., Long L.H., Halliwell B. Different patterns of oxidized lipid products in plasma and urine of dengue fever, strole and Parkinsons's disease: cautions in the use of biomarkers of oxidative stress. Antioxid. Redox Signal. 2009, 11:407-420.
10. Dzeletovic S., Breuer O., Lund E.E., Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution masss spectrometry. Anal. Biochem. 1995, 225:73-80.
11. Lee C.Y., Huang S.H., Jenner A.M., Haliwell B. Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products and oxysterol in single plasma sample. Free Radic. Biol. Med. 2008, 44:1314-1322.
12. Seet R.C., Lee C.Y., Lim E.C., Tan J.J., Quek A.M., Chong W.L., Looi W.F., Huang S.H., Wang H., Chan Y.H., Halliwell B. Oxidative damage in Parkinson disease. Measurement using accurate biomakers. Free Radic. Biol. Med. 2010, 48:560-566.